Oxford, United Kingdom

Antra Zeltina

This inventor holds 1 USPTO granted patent. Top assignees: Micropharm Limited, Oxford University Innovation Ltd, The Secretary of State for Health. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antra Zeltina. Retrieved from https://idiyas.com/inventor/antra-zeltina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antra Zeltina: Innovator in Filovirus Therapy

Introduction

Antra Zeltina is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of medical science, particularly in the development of therapies for viral diseases. Her work focuses on creating innovative solutions to combat serious health threats.

Latest Patents

Antra Zeltina holds a patent for her invention titled "Filovirus therapy." This patent provides antibodies that are used in the treatment, suppression, and prevention of Filovirus diseases, particularly Ebola virus disease. Additionally, her invention includes immunogens that are designed to elicit such antibodies, showcasing her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Antra has worked with notable organizations, including the Secretary of State for Health and Micropharm Limited. Her experience in these institutions has allowed her to develop her expertise in virology and therapeutic interventions.

Collaborations

Antra has collaborated with esteemed colleagues, including Miles Carroll and Stuart Dowall. These partnerships have contributed to her innovative research and the successful development of her patented therapies.

Conclusion

Antra Zeltina's work in Filovirus therapy exemplifies her dedication to improving public health through innovation. Her contributions to the field are invaluable, and her patent reflects her commitment to combating viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…